Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
JCO Global Oncology|July 9, 2020
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare CancersAlannah Smrke, Eugenie Younger, Roger Wilson, et al.
Nuklearmedizin. Nuclear Medicine|September 3, 2021
Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intentSheima Farag, Nikki S IJzerman, Matthijs P M Houdijk, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2017
Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patientsSheima Farag, Neeta Somaiah, Haesun Choi, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2021
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European studyMahmoud Mohammadi, Nikki S IJzerman, Peter Hohenberger, et al.
Oncotarget|March 24, 2018
A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumorsPieter A Boonstra, Arja Ter Elst, Marco Tibbesma, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case seriesCatriona Harvey, Kazi J Nahar, Janet McKeown, et al.
Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Nature Cancer|December 24, 2021
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studyAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Pageof 3